Template:Hypolipoproteinemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
!
!
[[Hypolipoproteinemia (patient information)|Patient Information]]
[[Hypolipoproteinemia (patient information)|Patient Information]]
|-
!
|- bgcolor="LightCoral"
!
'''Hypolipoprotein Disorders:'''
|-  
|-  
!
!
Line 21: Line 27:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Abetalipoproteinemia]]
:[[Abetalipoproteinemia]]
|-  
|-  
!
!
Line 27: Line 33:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hypobetalipoproteinemia]]
:[[Hypobetalipoproteinemia]]
|-  
|-  
!
!
Line 33: Line 39:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lecithin cholesterol acyltransferase deficiency|LCAT Deficiency]]
:[[Lecithin cholesterol acyltransferase deficiency|LCAT Deficiency]]
|-  
|-  
!
!
Line 39: Line 45:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Tangier's disease]]
:[[Tangier's disease]]
|-  
|-  
!
!
Line 45: Line 51:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Chylomicron retention disease]]
:[[Chylomicron retention disease]]
|-  
|-  
!
!
Line 51: Line 57:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[PCSK9 deficiency]]
:[[PCSK9 deficiency]]
|-  
|-  
!
!
Line 57: Line 63:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Familial combined hyperlipidemia]]
:[[Familial combined hyperlipidemia]]
|-  
|-  
!
!

Revision as of 22:03, 3 November 2016